v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (5,017,894) $ (5,278,904)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,294 1,293
Stock-based compensation 856,423 729,370
Changes in operating assets and liabilities:    
Accounts receivable (58,335)
Prepaid expenses and other assets (167,928) (212,655)
Investments (58,335)
Accounts payable (267,722) (12,282)
Accrued expenses 375,227 434,964
Net cash used in operating activities (4,337,270) (4,338,214)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from sale of common stock from ATM, net of issuance costs 941,393
Proceeds from issuance of common stock and warrants, net of issuance costs 5,674,651
Proceeds from warrant exercises 105,816
Proceeds from short term insurance financing 181,797 561,885
Payments on short term insurance financing (126,191) (389,880)
Net cash provided by financing activities 996,999 5,952,472
Net (decrease) increase in cash and cash equivalents (3,340,271) 1,614,258
Cash and cash equivalents, beginning of period 5,435,983 2,624,730
Cash and cash equivalents, end of period 2,095,712 4,238,988
Supplemental cash flow information:    
Cash paid for interest 5,007 16,150
Cash paid for taxes
Supplemental disclosures of noncash investing and financing activities    
Issuance of common stock as commitment fee in advance of equity transaction $ 207,493

Source

HTML PDF
ZIP